Status: affected by circulating vaccine-derived poliovirus type 2 (cVDPV2)
A circulating vaccine-derived poliovirus type 2 (cVDPV2) has been confirmed in Indonesia. Genetically-linked cVDPV2s were isolated from an acute flaccid paralysis (AFP) case (a seven-year old boy with onset of paralysis on 9 October 2022) and three healthy community contacts, from Aceh province.
Polio this week in Indonesia
- No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported this week. There is one case reported in the country in 2022.
International Health Regulations
As per the advice of an Emergency Committee convened under the International Health Regulations (2005), the risk of international spread of poliovirus remains a Public Health Emergency of International Concern (PHEIC). Countries affected by poliovirus transmission are subject to Temporary Recommendations. To comply with the Temporary Recommendations issued under the PHEIC, any country infected by poliovirus should declare the outbreak as a national public health emergency, ensure the vaccination of residents and long-term visitors and restrict at the point of departure travel of individuals, who have not been vaccinated or cannot prove the vaccination status. The latest report by the Committee is as of October 2022.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.